Industry: Medical Devices & Consumables
Published Date: 2025-01-19
Pages: 92 Pages
Report ld: 3425649
Request Sample
Customized Report
Diabetes Testing Program Market Size(US$)

CAGR 2025-2031
7.5%
Market Size,2031
USD 4,134
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.
This report aims to provide a comprehensive presentation of the global market for Diabetes Testing Program, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Testing Program.
The Diabetes Testing Program market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Testing Program market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Testing Program companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Testing Program company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HbA1c Test
1.2.3 Finger-prick Test
1.3 Market by Application
1.3.1 Global Diabetes Testing Program Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Diagnosis
1.3.3 Home Test
1.3.4 Lab Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Testing Program Market Perspective (2020-2031)
2.2 Global Diabetes Testing Program Growth Trends by Region
2.2.1 Global Diabetes Testing Program Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetes Testing Program Historic Market Size by Region (2020-2025)
2.2.3 Diabetes Testing Program Forecasted Market Size by Region (2026-2031)
2.3 Diabetes Testing Program Market Dynamics
2.3.1 Diabetes Testing Program Industry Trends
2.3.2 Diabetes Testing Program Market Drivers
2.3.3 Diabetes Testing Program Market Challenges
2.3.4 Diabetes Testing Program Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Testing Program Players by Revenue
3.1.1 Global Top Diabetes Testing Program Players by Revenue (2020-2025)
3.1.2 Global Diabetes Testing Program Revenue Market Share by Players (2020-2025)
3.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Testing Program Revenue
3.4 Global Diabetes Testing Program Market Concentration Ratio
3.4.1 Global Diabetes Testing Program Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2024
3.5 Global Key Players of Diabetes Testing Program Head office and Area Served
3.6 Global Key Players of Diabetes Testing Program, Product and Application
3.7 Global Key Players of Diabetes Testing Program, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Testing Program Breakdown Data by Type
4.1 Global Diabetes Testing Program Historic Market Size by Type (2020-2025)
4.2 Global Diabetes Testing Program Forecasted Market Size by Type (2026-2031)
5 Diabetes Testing Program Breakdown Data by Application
5.1 Global Diabetes Testing Program Historic Market Size by Application (2020-2025)
5.2 Global Diabetes Testing Program Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetes Testing Program Market Size (2020-2031)
6.2 North America Diabetes Testing Program Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetes Testing Program Market Size by Country (2020-2025)
6.4 North America Diabetes Testing Program Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Testing Program Market Size (2020-2031)
7.2 Europe Diabetes Testing Program Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetes Testing Program Market Size by Country (2020-2025)
7.4 Europe Diabetes Testing Program Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Testing Program Market Size (2020-2031)
8.2 Asia-Pacific Diabetes Testing Program Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetes Testing Program Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetes Testing Program Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Testing Program Market Size (2020-2031)
9.2 Latin America Diabetes Testing Program Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetes Testing Program Market Size by Country (2020-2025)
9.4 Latin America Diabetes Testing Program Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Testing Program Market Size (2020-2031)
10.2 Middle East & Africa Diabetes Testing Program Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetes Testing Program Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetes Testing Program Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Diabetes Testing Program Introduction
11.1.4 Roche Revenue in Diabetes Testing Program Business (2020-2025)
11.1.5 Roche Recent Development
11.2 LifeScan
11.2.1 LifeScan Company Details
11.2.2 LifeScan Business Overview
11.2.3 LifeScan Diabetes Testing Program Introduction
11.2.4 LifeScan Revenue in Diabetes Testing Program Business (2020-2025)
11.2.5 LifeScan Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetes Testing Program Introduction
11.3.4 Abbott Laboratories Revenue in Diabetes Testing Program Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Ascensia
11.4.1 Ascensia Company Details
11.4.2 Ascensia Business Overview
11.4.3 Ascensia Diabetes Testing Program Introduction
11.4.4 Ascensia Revenue in Diabetes Testing Program Business (2020-2025)
11.4.5 Ascensia Recent Development
11.5 Arkray
11.5.1 Arkray Company Details
11.5.2 Arkray Business Overview
11.5.3 Arkray Diabetes Testing Program Introduction
11.5.4 Arkray Revenue in Diabetes Testing Program Business (2020-2025)
11.5.5 Arkray Recent Development
11.6 I-SENS
11.6.1 I-SENS Company Details
11.6.2 I-SENS Business Overview
11.6.3 I-SENS Diabetes Testing Program Introduction
11.6.4 I-SENS Revenue in Diabetes Testing Program Business (2020-2025)
11.6.5 I-SENS Recent Development
11.7 Omron
11.7.1 Omron Company Details
11.7.2 Omron Business Overview
11.7.3 Omron Diabetes Testing Program Introduction
11.7.4 Omron Revenue in Diabetes Testing Program Business (2020-2025)
11.7.5 Omron Recent Development
11.8 Braun
11.8.1 Braun Company Details
11.8.2 Braun Business Overview
11.8.3 Braun Diabetes Testing Program Introduction
11.8.4 Braun Revenue in Diabetes Testing Program Business (2020-2025)
11.8.5 Braun Recent Development
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens Diabetes Testing Program Introduction
11.9.4 Siemens Revenue in Diabetes Testing Program Business (2020-2025)
11.9.5 Siemens Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Diabetes Testing Program Introduction
11.10.4 Bio-Rad Laboratories Revenue in Diabetes Testing Program Business (2020-2025)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Tosoh
11.11.1 Tosoh Company Details
11.11.2 Tosoh Business Overview
11.11.3 Tosoh Diabetes Testing Program Introduction
11.11.4 Tosoh Revenue in Diabetes Testing Program Business (2020-2025)
11.11.5 Tosoh Recent Development
11.12 Danaher Corporation
11.12.1 Danaher Corporation Company Details
11.12.2 Danaher Corporation Business Overview
11.12.3 Danaher Corporation Diabetes Testing Program Introduction
11.12.4 Danaher Corporation Revenue in Diabetes Testing Program Business (2020-2025)
11.12.5 Danaher Corporation Recent Development
11.13 Trinity Biotech
11.13.1 Trinity Biotech Company Details
11.13.2 Trinity Biotech Business Overview
11.13.3 Trinity Biotech Diabetes Testing Program Introduction
11.13.4 Trinity Biotech Revenue in Diabetes Testing Program Business (2020-2025)
11.13.5 Trinity Biotech Recent Development
11.14 HUMAN Diagnostics
11.14.1 HUMAN Diagnostics Company Details
11.14.2 HUMAN Diagnostics Business Overview
11.14.3 HUMAN Diagnostics Diabetes Testing Program Introduction
11.14.4 HUMAN Diagnostics Revenue in Diabetes Testing Program Business (2020-2025)
11.14.5 HUMAN Diagnostics Recent Development
11.15 Terumo
11.15.1 Terumo Company Details
11.15.2 Terumo Business Overview
11.15.3 Terumo Diabetes Testing Program Introduction
11.15.4 Terumo Revenue in Diabetes Testing Program Business (2020-2025)
11.15.5 Terumo Recent Development
11.16 Sinocare
11.16.1 Sinocare Company Details
11.16.2 Sinocare Business Overview
11.16.3 Sinocare Diabetes Testing Program Introduction
11.16.4 Sinocare Revenue in Diabetes Testing Program Business (2020-2025)
11.16.5 Sinocare Recent Development
11.17 Acon Biotech
11.17.1 Acon Biotech Company Details
11.17.2 Acon Biotech Business Overview
11.17.3 Acon Biotech Diabetes Testing Program Introduction
11.17.4 Acon Biotech Revenue in Diabetes Testing Program Business (2020-2025)
11.17.5 Acon Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 129
USD 3950.00
(Single User License)
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 122
USD 4350.00
(Single User License)
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Published Date: 2024-03-20
Pages: 197
USD 4900.00
(Single User License)
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 129
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 122
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
Published: 2024-03-20
Pages: 197
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now